Tertiapin-Q
Selleck Chemicals
SKU:E0016-5MG
Couldn't load pickup availability

Tertiapin-Q is an inhibitor of Potassium Channels used in studies of ion-channel pharmacology. It is especially relevant in cardiovascular and neuroscience models, where defined compound exposure can be linked to ion conductance, membrane potential, and electrophysiological responses.
By inhibiting Potassium Channels, Tertiapin-Q can be used to examine ion conductance, membrane potential, and electrophysiological responses. This target class is commonly examined through electrophysiology, ion-flux, and membrane-potential studies, together with downstream-response mapping. In cardiovascular and neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving Potassium Channels
- Concentration-response inhibition and target-dependence studies
- Electrophysiology, ion-flux, and membrane-potential studies
- Phenotypic profiling in cardiovascular and neuroscience models
Overall, Tertiapin-Q is appropriate when a defined chemical perturbant is needed to connect Potassium Channels with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular and neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- Potassium Channels
- Target Class:
- Ion Channel
- Research Area:
- Cardiovascular • Neuroscience
- CAS No.:
- 910044-56-3
- Molecular Weight:
- 2452.00
- Formula:
- C₁₀₆H₁₇₅N₃₅O₂₄S₄
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.